Prostaglandin E receptor subtype EP4 agonist protects cochleae against noise-induced trauma

Neuroscience

Volumn 160, Issue 4, 2009, Pages 813-819

  Hori, R ^a   Nakagawa, T ^a   Sugimoto, Y ^a   Sakamoto, T ^a   Yamamoto, N ^a   Hamaguchi, K ^a   Ito, J ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

acoustic trauma; hair cell; hearing loss; inner ear; prostanoid

Indexed keywords

PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN E RECEPTOR 4; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUDITORY THRESHOLD; COCHLEA INJURY; CONTROLLED STUDY; EAR PROTECTION; EVOKED BRAIN STEM AUDITORY RESPONSE; GUINEA PIG; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NOISE INJURY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ALPROSTADIL; ANIMALS; AUDITORY THRESHOLD; COCHLEA; DISEASE MODELS, ANIMAL; EVOKED POTENTIALS, AUDITORY, BRAIN STEM; GUINEA PIGS; HAIR CELLS, AUDITORY; HEARING LOSS, NOISE-INDUCED; HEARING LOSS, SENSORINEURAL; IMMUNOHISTOCHEMISTRY; MALE; METHYL ETHERS; MICE; MICE, INBRED C57BL; NEUROPROTECTIVE AGENTS; NOISE; RECEPTORS, PROSTAGLANDIN E; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 64649087758     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2009.03.014     Document Type: Article

References (30)

1. Ahmad A.S., Ahmad M., de Brum-Fernandes A.J., and Doré S. Prostaglandin EP4 receptor agonist protects against acute neurotoxicity. Brain Res 1066 (2005) 71-77
2. Ahn J.H., Kim M.R., and Kim H.C. Therapeutic effect of lipoprostaglandin E1 on sudden hearing loss. Am J Otolaryngol 26 (2005) 245-248
3. Alam S.A., Robinson B.K., Huang J., and Green S.H. Prosurvival and proapoptotic intracellular signaling in rat spiral ganglion neurons in vivo after the loss of hair cells. J Comp Neurol 503 (2007) 832-852
4. 1 on vascular endothelial growth factor production by human macrophages and colon cancer cells. J Exp Clin Cancer Res 19 (2000) 219-223
5. Bok J., Zha X.M., Cho Y.S., and Green S.H. An extranuclear locus of cAMP-dependent protein kinase action is necessary and sufficient for promotion of spiral ganglion neuronal survival by cAMP. J Neurol Sci 23 (2003) 777-787
6. Coleman R.A., Smith W.L., and Narumiya S. International union of pharmacology classification of prostanoid receptors: properties, distribution and structure of the receptors and their subtypes. Pharmacol Rev 46 (1994) 205-229
7. Echeverria V., Clerman A., and Doré S. Stimulation of PGE receptors EP2 and EP4 protects cultured neurons against oxidative stress and cell death following beta-amyloid exposure. Eur J Neurosci 22 (2005) 2199-2206
8. 2 stimulates VEGF expression in primary rat gastric fibroblasts through EP4 receptors. Inflammopharmacology 15 (2007) 214-217
9. Inaoka T., Nakagawa T., Kikkawa Y.S., Tabata Y., Ono K., Yoshida M., Tsubouchi H., Ido A., and Ito J. Local application of hepatocyte growth factor using gelatin hydrogels attenuates noise-induced hearing loss in guinea pigs. Acta Otolaryngol 129 (2009) 453-457
10. Kabashima K., Saji T., Murata T., Nagamachi M., Matsuoka T., Segi E., Tsuboi K., Sugimoto Y., Kobayashi T., Miyachi Y., Ichikawa A., and Narumiya S. The prostaglandin receptor EP4 suppresses colitis, mucosal damage and CD4 cell activation in the gut. J Clin Invest 109 (2002) 883-893
11. 2 receptor EP4 agonist induces Bcl-xL and independently activates proliferation signals in mouse primary hepatocytes. J Gastroenterol 40 (2005) 610-616
12. Kiriyama M., Ushikubi F., Kobayashi T., Hirata M., Sugimoto Y., and Narumiya S. Ligand binding specificities of the eight types and subtypes of the mouse prostanoid receptors expressed in Chinese hamster ovary cells. Br J Pharmacol 122 (1997) 217-224
13. 1 in patients with peripheral arterial disease, accompanied by up-regulation of hepatocyte growth factor. Hypertens Res 27 (2004) 85-91
14. Nakashima T., Naganawa S., Sone M., Tominaga M., Hayashi H., Yamamoto H., Liu X., and Nuttall A.L. Disorders of cochlear blood flow. Brain Res Brain Res Rev 43 (2003) 17-28
15. Narumiya S., Sugimoto Y., and Ushikubi F. Prostanoid receptors: structures, properties, and functions. Physiol Rev 79 (1999) 1193-1226
16. 2 receptor subtype with rat dextran sodium sulphate colitis: colitis suppression by a selective agonist, ONO-AE1-329. Scand J Immunol 56 (2002) 66-75
17. 1 on idiopathic sudden sensorineural hearing loss: a double-blinded clinical study. Otol Neurotol 23 (2002) 665-668
18. Oshima K., Shimamura M., Mizuno S., Tamai K., Doi K., Morishita R., Nakamura T., Kubo T., and Kaneda Y. Intrathecal injection of HVJ-E containing HGF gene to cerebrospinal fluid can prevent and ameliorate hearing impairment in rats. FASEB J 18 (2004) 212-214
19. Pai R., Szabo I.L., Soreghan B.A., Atay S., Kawanaka H., and Tarnawski A.S. PGE(2) stimulates VEGF expression in endothelial cells via ERK2/JNK1 signaling pathways. Biol Chem Biophys Res Commun 286 (2001) 923-928
20. Picciotti P.M., Fetoni A.R., Paludetti G., Wolf F.I., Torsello A., Troiani D., Ferraresi A., Pola R., and Sergi B. Vascular endothelial growth factor (VEGF) expression in noise-induced hearing loss. Hear Res 214 (2006) 76-83
21. Pujol R., and Puel J.L. Excitotoxicity, synaptic repair, and functional recovery in the mammalian cochlea: a review of recent findings. Ann N Y Acad Sci 884 (1999) 249-254
22. Rhee C.K., Park Y.S., Jung T.T., and Park C.I. Effects of leukotrienes and prostaglandins on cochlear blood flow in the chinchilla. Eur Arch Otorhinolaryngol 256 (1999) 479-483
23. Ruel J., Wang J., Rebillard G., Eybalin M., Lloyd R., Pujol R., and Puel J.L. Physiology, pharmacology and plasticity at the inner hair cell synaptic complex. Hear Res 227 (2007) 19-27
24. 1 versus steroid in combination with hyperbaric oxygen therapy for idiopathic sudden sensorineural hearing loss. Auris Nasus Larynx 35 (2008) 192-197
25. 1 applied topically to the round window. Acta Otolaryngol 126 (2006) 232-236
26. Viberg A., and Canlon B. The guide to plotting a cochleogram. Hear Res 197 (2004) 1-10
27. Wei B.P., Mubiru S., and O'Leary S. Steroids for idiopathic sudden sensorineural hearing loss. Cochrane Database Syst Rev 25 (2006) CD003998
28. 1 induces vascular endothelial growth factor-1 in human adult cardiac myocytes but not in human adult cardiac fibroblasts via a cAMP-dependent mechanism. Mol Cell Cardiol 36 (2004) 539-546
29. Zhang L., Himi T., and Murota S. Induction of hepatocyte growth factor (HGF) in rat microglial cells by prostaglandin E(2). J Neurosci Res 62 (2000) 389-395
30. 1 effective for the treatment of sudden hearing loss?. An evidence-based meta-analysis. J Int Med Res 36 (2008) 467-470